Cargando…
PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease
In the present study, we used a mouse model of Alzheimer’s disease (AD) (3×Tg-AD mice) to longitudinally analyse the expression level of PDIA3, a protein disulfide isomerase and endoplasmic reticulum (ER) chaperone, in selected brain limbic areas strongly affected by AD-pathology (amygdala, entorhin...
Autores principales: | Cassano, Tommaso, Giamogante, Flavia, Calcagnini, Silvio, Romano, Adele, Lavecchia, Angelo Michele, Inglese, Francesca, Paglia, Giuliano, Bukke, Vidyasagar Naik, Romano, Antonino Davide, Friuli, Marzia, Altieri, Fabio, Gaetani, Silvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918299/ https://www.ncbi.nlm.nih.gov/pubmed/36769334 http://dx.doi.org/10.3390/ijms24033005 |
Ejemplares similares
-
Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
por: Cassano, Tommaso, et al.
Publicado: (2019) -
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
por: Cassano, Tommaso, et al.
Publicado: (2017) -
A Comparative Analysis of Punicalagin Interaction with PDIA1 and PDIA3 by Biochemical and Computational Approaches
por: Paglia, Giuliano, et al.
Publicado: (2021) -
ERp57/PDIA3: new insight
por: Chichiarelli, Silvia, et al.
Publicado: (2022) -
Comparative Analysis of the Interaction between Different Flavonoids and PDIA3
por: Giamogante, Flavia, et al.
Publicado: (2016)